A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia

Biological Psychiatry

Volumn 61, Issue 10, 2007, Pages 1200-1203

  Morita, Yukitaka ^a   Ujike, Hiroshi ^a   Tanaka, Yuji ^a   Otani, Kyohei ^a   Kishimoto, Makiko ^a   Morio, Akiko ^a   Kotaka, Tatsuya ^a   Okahisa, Yuko ^a   Matsushita, Masayuki ^a   Morikawa, Akiko ^b   Hamase, Kenji ^b   Zaitsu, Kiyoshi ^b   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Case control study; column switching high performance liquid chromatography system; promoter activity; schizophrenia; serine racemase; single nucleotide polymorphism

Indexed keywords

DEXTRO SERINE; RACEMASE; SERINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RACEMASES AND EPIMERASES; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIA, PARANOID; SERINE;

EID: 34247596490     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.07.025     Document Type: Article

References (19)

1. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415 (2002) 793-798
2. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393 (1998) 377-381
3. De Miranda J., Santoro A., Engelender S., and Wolosker H. Human serine racemase: Moleular cloning, genomic organization and functional analysis. Gene 256 (2000) 183-188
4. Goltsov A.Y., Loseva J.G., Andreeva T.V., Grigorenko A.P., Abramova L.I., Kaleda V.G., et al. Polymorphism in the 5′-promoter region of serine racemase gene in schizophrenia. Mol Psychiatry 11 (2006) 325-326
5. Hashimoto Y., Omae F., and Furukawa S. Reduction of NGF protein level in rat dorsal hippocampus following administration of kainic acid. Neurosci Lett 140 (1992) 203-205
6. Jackson M.E., Homayoun H., and Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A 101 (2004) 8467-8472
7. Morikawa A., Hamase K., Inoue T., Konno R., Niwa A., and Zaitsu K. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J Chromatogr B Biomed Sci Appl 757 (2001) 119-125
8. Morris R.G., Anderson E., Lynch G.S., and Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319 (1986) 774-776
9. Muller D., Joly M., and Lynch G. Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. Science 242 (1988) 1694-1697
10. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995) 998-1007
11. Olney J.W., Ikonomidou C., Mosinger J.L., and Frierdich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9 (1989) 1701-1704
12. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., and Sesma M.A. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254 (1991) 1515-1518
13. Panizzutti R., De Miranda J., Ribeiro C.S., Engelender S., and Wolosker H. A new strategy to decrease N-methyl-D-aspartate (NMDA) receptor coactivation: Inhibition of D-serine synthesis by converting serine racemase into an eliminase. Proc Natl Acad Sci U S A 98 (2001) 5294-5299
14. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., et al. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum Genet 13 (2005) 807-814
15. Wolosker H., Blackshaw S., and Snyder S.H. Serine racemase: A glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A 96 (1999) 13409-13414
16. Xia M., Liu Y., Figueroa D.J., Chiu C.S., Wei N., Lawlor A.M., et al. Characterization and localization of a human serine racemase. Brain Res Mol Brain Res 125 (2004) 96-104
17. Wolosker H., Sheth K.N., Takahashi M., Mothet J.P., Brady Jr. R.O., Ferris C.D., and Snyder S.H. Purification of serine racemase: Biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A 96 (1999) 721-725
18. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., et al. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol Psychiatry 57 (2005) 1493-1503
19. Zhao X., Li H., Shi Y., Tang R., Chen W., Liu J., et al. Significant association between the genetic variations in the 5′ end of the N-methyl-D-aspartate receptor subunit gene GRIN1 and schizophrenia. Biol Psychiatry 59 (2006) 747-753